MSN Labs

MSN Group launches Fesobig to treat urinary incontinence and overactive bladder

Read more

MSN Labs launches generic tablet Palborest for breast cancer treatment

Read more

MSN Labs launches Empagliflozin tablets for diabetes management in India

Read more

Lilly signs voluntary licensing agreement with Natco for baricitinib

Read more

Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow

Read more